Clinical Trial

Gel for Male Contraception

Study Description

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

The long term objective is to develop a gel to be used as a male contraceptive.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Nestorone + Testosterone Combination Gel

The combined gel is a transdermal treatment that will be applied daily for 52 weeks to a male subject's arms and shoulders. The formulation will be a hydro alcoholic gel containing about 1.43% T (14.3 mg T/g gel). About 9 to 14% of the steroid (T or NES) in the gel applied is available to the body. The amount of gel to be applied each application will be approximately 5 mL in volume. The gel application volume will contain 62 mg of T that will deliver approximately 6 mg T to the body per day. Th ...read more on ClinicalTrials.org

Additional Information

Official Study Title

Clinical Evaluation of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Clinical Trial ID

NCT03452111

ParticipAid ID

9avPMd